Synthesis,characterization and antimicrobial activity of zinc(II) ibuprofen complexes with nitrogen-based ligands

Metal carboxylate complexes possess different carboxylate coordination modes, e.g. monodentate, bidentate, and bridging bidentate. Five Zn(II) complexes were prepared and characterized in order to examine their coordination modes in addition to their biological activity. The syntheses were started by preparation of [Zn(ibup)₂(H₂O)₂] (1). Then, different nitrogen-donor ligands reacted with 1 to produce [Zn(ibup)₂(2-ampy)₂] (2), [Zn(ibup)(2-ammethylpy)] (3), [Zn(ibup)(2,2′-bipy)] (4), and [Zn₂(ibup)₄(2-methylampy)₂] (5) (ibup = ibuprofen, 2-ampy = 2-aminopyridine, 2-ammethylpy = 2-aminomethylpyridine, 2,2′-bipy = 2,2′-bipyridine, 2-methylampy = 2-(methylamino)pyridine). IR, ¹H NMR, ¹³C{¹H}-NMR and UV–vis spectroscopies were used for characterization. The crystal structures of 2 and 5 were determined by single-crystal X-ray diffraction. Investigation of in vitro antibacterial activities for the complexes against Gram-positive (Micrococcus luteus, Staphylococcus aureus and Bacillus subtilis) and Gram-negative (Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis) bacteria were done using agar well-diffusion method. Complex 1 showed antibacterial activity against Gram-positive bacteria. Complexes 2 and 3 did not exhibit antibacterial activity. Complex 4 showed antibacterial activity and was chosen for further studies to determine the inhibition zone diameter for different concentrations and to set the minimum inhibitory concentration. The antibacterial activity against most of the bacteria was minimized as a result of the complexation of zinc ibuprofen with 2,2′-bipy in 4.     

New Zn(II) complexes based on biologically active substituted acetic acid and nitrogen donor ligands: synthesis,crystal structure and biological applications

The complexes [Zn(phenylacetato)₂(2-aminopyridin)₂] (3), [Zn(phenylacetato)₂(1,10-phenanthroline)]·H₂O (4), and [Zn(phenylacetato)₂(2,9-dimethyl-1,10-phenanthroline)]·0.5 H₂O (5) were prepared and characterized by IR-, UV–Visible, ¹H and ¹³C NMR spectroscopy, and single crystal X-ray diffraction. BNPP hydrolysis of the complexes and their parent nitrogen ligands showed that the hydrolysis rate of bis-(4-nitrophenyl) phosphate (BNPP) was 1.7 × 10⁵ L mol^?1 s^?1 for 3, 3.1 × 10⁵ L mol^?1 s^?1 for 4 and 4.3 × 10⁴ L mol^?1 s^?1 for 5. Antibacterial activities show the effect of complexation on activity against Gram-positive (S. epidermidis, S. aureus, E. faecalis, M. luteus and B. subtilis) and Gram-negative (K. pneumonia, E. coli, P. mirabilis and P. aeruginosa) bacteria using the agar well diffusion method. Complex 4 showed good activity against G? bacteria except P. aeruginosa, and against G+ bacteria except E. ferabis. Complex 5 showed no activity against G? bacteria, low activity against M. luteus and B. subtilis bacteria and high activity against S. epidemidis and S. aureus. Complex 3 did not show any activity against G? or G+ bacteria.     

Synthesis,characterization and in vitro biological activity of new zinc(II) complexes of the nonsteroidal anti‐inflammatory drug sulindac and nitrogen‐donor ligands

Metal carboxylate compounds with nitrogen‐ and/or oxygen‐donor ligands with various carboxylate coordination modes, monodentate, bidentate and bridging bidentate, have been shown to be important from biological and chemical aspects. Five zinc ion binary compounds, diaqua‐bis‐(2‐((E )‐5‐fluoro‐2‐methyl‐1‐(4‐(methylsulfinyl)benzylidene)‐1H –inden‐3‐yl)acetato)zinc(II) ( 1 ), aqua‐bis‐(2‐((E )‐5‐fluoro‐2‐methyl‐1‐(4‐(methylsulfinyl)benzylidene)‐1H –inden‐3‐yl)acetato)pyridin‐2‐aminezinc(II) ( 2 ), (2‐((E )‐5‐fluoro‐2‐methyl‐1‐(4‐(methylsulfinyl)benzylidene)‐1H –inden‐3‐yl)acetato) pyridin‐2‐ylmethanaminezinc(II) (2‐((E )‐5‐fluoro‐2‐methyl‐1‐(4‐(methylsulfinyl)benzylidene)‐1H –inden‐3‐yl)acetate) ( 3 ), bis‐(2‐((E )‐5‐fluoro‐2‐methyl‐1‐(4‐(methylsulfinyl)benzylidene)‐1H –inden‐3‐yl)acetato)‐1,10‐phenanthrolinezinc(II) ( 4 ) and bis‐(2‐((E )‐5‐fluoro‐2‐methyl‐1‐(4‐(methylsulfinyl)benzylidene)‐1H –inden‐3‐yl)acetato)‐1,10‐phenanthrolinezinc(II) ( 5 ), have been prepared and fully characterized. In addition, the complexes were evaluated for their antibacterial activity using the in vitro agar diffusion method against two Gram‐positive (Staphylococcus epidermidis , Staphylococcus aureus ) and two Gram‐negative (Bordetella , Escherichia coli ) bacteria and yeast species (Saccharomyces and Candida ). Complex 5 showed reasonable activity against yeast. All compounds showed greater antibacterial activity against Gram‐positive than Gram‐negative bacteria. Results indicated that the efficiency of complex 5 in preventing the formation of β‐hematin was 67.6%. The efficiency of chloroquine as a standard drug was reported as 93%. Furthermore, the phosphatase activity of the Zn(II) complexes was studied and results indicated an effect of the zinc complexes on phosphatase activity.     

Novel structures of Zn(II) biometal cation with the biologically active substituted acetic acid and nitrogen donor ligands: Synthesis,spectral, phosphate diester catalytic hydrolysis and anti‐microbial studies

The complexes [Zn(methoxyacetate)₂1,10‐phenanthroline] 1 and [Zn₂(phenylacetate)₄(quinoline)₂] 2 , were prepared and characterized by IR‐spectroscopy, UV–Visible spectroscopy, ¹H and ¹³C NMR spectroscopy, single crystal X‐ray diffraction. BNPP hydrolysis of the complexes and their parent nitrogen ligands were scanned, the results indicated that the hydrolysis rates of BNPP were 4.5 × 10⁴ and 6.2 × 10⁵ for ( 1 ) and ( 2 ), respectively. In addition, anti‐bacterial activities were scanned to investigate the effect of complexation on their activity against Gram‐positive (S. epidermidis , S. aureus , E. faecalis , M. luteus and B. Subtilis ) and Gram‐negative (K. pneumonia , E. coli , P. Mirabilis and P. Aeruginosa ) bacteria using agar well‐diffusion method. Complex 1 showed high activity against G⁻and G ⁺ bacteria except against E. faecalis and P. Aeruginosa . Complex 2 did not show any activity against G⁻ or G ⁺ bacteria.     

Manganese (II) complexes of some nitrogen-oxygen and nitrogen-sulphur donor ligands

Manganese(II) complexes of the general composition, Mn(L)₂X₂ (X = Cl or 1/2 SO₄,L = semicarbazones and thiosemicarbazones of acetone, ethyl methyl ketone and 2-methyl cyclohexanone) have been prepared and characterised by elemental analysis, magnetic moments, conductance measurements, IR, electronic and ESR spectral studies. All the complexes are six-coordinate octahedral.     

Syntheses and characterization of nickel(II), zinc(II) and palladium(II) complexes derived from three pyrazole-based polydentate ligands

Two pyrazole-based polydentate ligands, 1,3-bis(5-methyl-3-phenylpyrazol-1-yl)-propan-2-ol (Hmppzpo) and 1,3-bis(5-methyl-3-p-isopropylphenylpyrazol-1-yl)-propan-2-ol (Hmcpzpo), have been synthesized. A third ligand, 1,3-bis(3,5-dimethylpyrazol-1-yl)-propan-2-ol (Hdmpzpo), has been synthetically modified. Seven new M(II) coordination compounds of general formula M₂L₂X₂ (M?=?Zn, Ni; X?=?NO₃ or ClO₄; L?=?dmpzpo, mppzpo or mcpzpo) or MLX (M?=?Pd; L?=?dmpzpo; X?=?Cl) were synthesized and structurally characterized by elemental analysis and FT-IR analysis. The crystal structures of [Zn₂(μ-dmpzpo-O,N,N′)₂(NO₃)₂]?·?2H₂O (1?·?2H₂O), [Ni₂(μ-dmpzpo-O,N,N′)₂(CH₃CN)₂](ClO₄)₂ (2) and Pd(μ-dmpzpo-N,N′)Cl₂ (4) were determined by single-crystal X-ray crystallography. The crystal structures show that complexes 1?·?2H₂O and 2 are center-symmetric dinuclear compounds, with two metal ions bridged by two alkoxo groups and each metal ion with a distorted square-pyramidal environment. The palladium complex, 4, displayed square-planar coordination geometry around the Pd(II) ion with trans arrangement.     

Organoplatinum(II) complexes with phosphite ligands

The phosphite complexes cis-[PtMe₂L(SMe₂)] in which L = P(OⁱPr)₃, 1a, or L = P(OPh)₃, 1b, were synthesized by the reaction of cis,cis-[Me₂Pt(μ-SMe₂)₂PtMe₂] with 2 equiv. of L. If 4 equiv. of L was used the bis-phosphite complexes cis-[PtMe₂L₂] in which L = P(OⁱPr)₃, 2a, or L = P(OPh)₃, 2b, were obtained. The reaction of cis-[Pt(p-MeC₆H₄)₂(SMe₂)₂] with 2 equiv. of L gave the aryl bis-phosphite complexes cis-[Pt(p-MeC₆H₄)₂L₂] in which L = P(OⁱPr)₃, 2a′, or L = P(OPh)₃, 2b′. Use of 1 equiv. of L in the latter reaction gave the bis-phosphite complex along with the starting complex in a 1:1 ratio.The complexes failed to react with MeI. The reaction of cis,cis-[Me₂Pt(μ-SMe₂)₂PtMe₂] with 2 equiv. of the phosphine PPh₃ gave cis-[PtMe₂(PPh₃)₂] and cis-[PtMe₂(PPh₃)(SMe₂)] along with unreacted starting material. Reaction of cis-[PtMe₂L(SMe₂)], 1a and 1b with the bidentate phosphine ligand bis(diphenylphosphino)methane, dppm = Ph₂PCH₂PPh₂, gave [PtMe₂(dppm)], 8, along with cis-[PtMe₂L₂], 2. The reaction of cis-[PtMe₂L(SMe₂)] with 1/2 equiv. of the bidentate N-donor ligand NN = 4,4′-bipyridine yielded the binuclear complexes [PtMe₂L(μ-NN)PtMe₂L] in which L = P(OⁱPr)₃, 3a, or L = P(OPh)₃, 3b.The complexes were fully characterized using multinuclear NMR (¹H, ¹³C, ³¹P, and ¹⁹⁵Pt) spectroscopy.     

Homolysis of the Ln-N bond: Synthesis, characterization and catalytic activity of organolanthanide(II) complexes with furfuryl- and tetrahydrofurfuryl-functionalized indenyl ligands

A series of new organolanthanide(II) complexes with furfuryl- and tetrahydrofurfuryl-functionalized indenyl ligands were synthesized via one-electron reductive elimination reaction. Treatments of [(Me₃Si)₂N]₃Ln^III(μ-Cl)Li(THF)₃ (Ln = Yb, Eu) with 2 equiv. of C₄H₇OCH₂C₉H₇ (1) or C₄H₃OCH₂C₉H₇ (2), respectively in toluene at moderate high temperatures produced, after workup, the corresponding organolanthanide(II) complexes with formula [η⁵:η¹-(C₄H₇OCH₂C₉H₆)]₂Ln^II (Ln = Yb (5), Ln = Eu (6)) and [η⁵:η¹-(C₄H₃OCH₂C₉H₆)]₂Ln^II (Ln = Yb (7), Ln = Eu (8)) in reasonable to good yields. Treatments of [(Me₃Si)₂N]₃Ln^III(μ-Cl)Li(THF)₃ (Ln = Yb, Eu) with 2 equiv. of C₄H₇OCH₂C₉H₆SiMe₃ (3) or C₄H₃OCH₂C₉H₆SiMe₃ (4), respectively, in toluene at moderate high temperatures afforded, after workup, the corresponding organolanthanide(II) complexes with formula [η⁵:η¹-(C₄H₇OCH₂C₉H₅SiMe₃)]₂Ln^II (Ln = Yb (9), Ln = Eu (10)) and[η⁵:η¹-(C₄H₃OCH₂C₉H₅SiMe₃)]₂Ln^II (Ln = Yb (11), Ln = Eu (12)) in good to high yields. All the compounds were fully characterized by spectroscopic methods and elemental analyses. The structure of complex 9 was additionally determined by single-crystal X-ray analyses. Studies on the catalytic activities of complexes showed that the complexes having silyl group functionalized indenyl ligands have high catalytic activities on ε-caprolactone polymerization. The temperatures, substituted groups on the indenyl ligands of the complexes, and solvents effects on the catalytic activities of the complexes were examined.     

Synthesis,characterization, DFT calculations and antimicrobial activity of pentagonal-bipyramidal Zn(II) and Cd(II) complexes with 2,6-diacetylpyridine-bis(trimethylammoniumacetohydrazone)

Isothiocyanate complexes of Zn(II) and Cd(II) with the condensation product of 2,6-diacetylpyridine and trimethylammoniumacetohydrazide (Girard’s T reagent) were synthesized, characterized, and their antimicrobial activities were evaluated. The structures of the complexes were determined by elemental analysis, IR, and NMR spectroscopy. The crystal structure of the Zn(II) complex was also determined. Quantum-chemical calculations of the geometry and total energy of isomers of 2,6-diacetylpyridine-bis(trimethylammoniumacetohydrazone) were performed in vacuum and methanol solution, with the aim to explain conformational behavior and E/Z isomerism of this compound. DFT calculations of the molecular structures and the relative stabilities of linkage isomers of the Cd(II) complex showed that the isomer with N–Cd–N coordination of SCN^? is the most stable. Complexes of Zn(II) and Cd(II) exhibited low to moderate activity against the tested microbial strains.     

Synthesis, characterization and catalytic activity of organolanthanide(II) complexes with heterocyclic-functionalized fluorenyl ligands

Two series of new organolanthanide(II) complexes with tetrahydro-2H-pyranyl- or N-piperidineethyl-functionalized fluorenyl ligands were synthesized via one-electron reductive elimination reaction. Treatments of [(Me₃Si)₂N]₃Ln^III(μ-Cl)Li(THF)₃ with 2 equiv. of C₅H₉OCH₂C₁₃H₉ (1) or C₅H₁₀NCH₂CH₂C₁₃H₉ (2), respectively, in toluene at about 80 °C produced, after workup, the corresponding organolanthanide(II) complexes with formula [η⁵:η¹-C₅H₉OCH₂C₁₃H₈]₂Ln^II (Ln = Yb (3), Ln = Eu (4)) and [η⁵:η¹-C₅H₁₀NCH₂CH₂C₁₃H₈]₂Ln^II (Ln = Yb (5), Ln = Eu (6)) in good yields. All the compounds were fully characterized by spectroscopic methods and elemental analyses. The structures of complexes 3, 4, and 6 were additionally determined by single-crystal X-ray analyses. It represents the first example of solvent-free organolanthanide(II) complexes with fluorenyl ligands. The catalytic properties of the organolanthanide(II) complexes on the polymerization of ε-caprolactone and methyl methacrylate have been studied. The temperatures, solvents and coordination effects on the catalytic activities of the complexes were examined.     

Platinum(II) complexes with bidentate iminopyridine ligands: Synthesis,spectral characterization,properties and structural analysis

Four platinum(II) complexes, [PtCl₂L] (L = (4-fluorophenyl)pyridin-2-ylmethylene-amine, 1; (4-chlorophenyl)pyridin-2-ylmethyleneamine, 2; (4-bromophenyl)pyridin-2-ylmethyleneamine, 3 and (4-iodophenyl)pyridin-2-ylmethyleneamine, 4) have been synthesized and characterized by CHN analysis, IR and UV–Vis spectroscopy. The crystal structures of 1 and 2 were determined using single crystal X-ray diffraction. The coordination polyhedron about the platinum (II) center in the complexes is best described as distorted square planar. The complexes undergo stacking to form a zigzag Pt···Pt···Pt chain containing both short (3.57(7) Å in 1 and 3.62(8) Å in 2) and long (5.16(7) Å in 1 and 5.41(9) Å in 2) Pt···Pt separations through the crystal. The compounds absorb moderately in the visible region, owing to a charge-transfer-to-diimine electronic transition. The redox potentials are approximately insensitive to the substituents on the phenyl ring of the ligands.     

Syntheses, crystal structures and properties of novel zinc(II) complexes obtained by reactions of zinc(II) malonate with flexible multidentate ligands

Complex [Zn₂(bimb)₂(mal)₂(H₂O)₂]·4H₂O (1) (mal=⁻OCOCH₂COO⁻) was obtained by reaction of bidentate ligand 4,4′-bis(imidazole-1-ylmethyl)biphenyl (bimb) with zinc(II) salt of malonate, while the reaction of the same metal salt with 1,3,5-tris(imidazol-1-ylmethyl)-2,4,6-trimethylbenzene (titmb) gives another novel complex [Zn₂(titmb)₂(mal)][mal]·12H₂O (2). The structures of these complexes were determined by X-ray crystallography. The results revealed that 1 is a cyclic dinuclear complex in which the malonate groups act as terminators and prevent further aggregation, while 2 is a 2D honeycomb network in which each independent 2D sheet contains two sub-layers bridged by the malonate groups and complex 2 also contains free malonate as a counteranion connected to the 2D layer by C-H?O hydrogen bonds. The entirely different structure and topology of complexes 1 and 2, on the one hand, indicates that the nature of organic ligands affected the structures of assemblies greatly, and on the other, reveals the versatility of the malonate which can act as a bridging and/or blocking ligand.     

Synthesis,characterization, crystal structures,and superoxide dismutase activity of copper(II) octahedral complexes containing tri- and monodentate ligands

Three new copper(II) complexes [Cu(PSBP)₂](NO₃)(BF₄) (1), [Cu(DAPBMA)₂](BF₄)₂ (2), and [Cu(ImH)₄(NO₃)₂] (3), where PSBP = 4-phenylsemicarbazide-2-benzoylpyridine, DAPBMA = 2,6-diacetylpyridine-bis-4-methoxyaniline, and ImH = Imidazole, have been synthesized and characterized by elemental analysis, FAB mass spectrometry, magnetic susceptibility, X-band electron paramagnetic resonance (EPR), electronic spectroscopy, and cyclic voltammetry. Frozen solution EPR spectra of the complexes have axial features with g _∥ > g _⊥ > 2.003 suggesting the presence of a d _{x ²? y ²} ground state. Single crystal X-ray analyses of 1–3 reveal the presence of distorted octahedral geometry. All complexes exhibit significant superoxide dismutase activity.     

Synthesis,structure, protein binding,and cytotoxicity of zinc(II) complexes with tridentate NNO Schiff-base ligands

Mononuclear and trinuclear zinc(II) complexes (1 and 2) with tridentate NNO Schiff-base ligands (HL¹?=?N-2-pyridiylmethylidene-4-chloro-2-hydroxy-phenylamine, HL²?=?N-2-pyridiylmethylidene-2-hydroxy-5-chloro-phenylamine) have been synthesized and characterized by single-crystal X-ray diffraction and elemental analysis. The binding properties of zinc(II) complexes with calf thymus DNA (CT-DNA) and HSA were investigated by UV–visible, fluorescence, and circular dichroism spectra. The zinc(II) complexes bind significantly to CT-DNA by intercalation and bind to protein HSA through a static quenching mechanism. The in vitro cytotoxicity of the complexes on human tumor cells lines was assessed by 3-(4,5-dimathylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide, Hoechst 33258 staining experiments.     

Antimicrobial,antioxidant and antitumor activities of Nano-Structure Eu (III) and La (III) complexes with nitrogen donor tridentate ligands

Nano structure metal complexes of Eu (III) and La (III) with two different nitrogen donor tridentate ligands: N-(2-Aminoethyl)-1,3-propanediamine “AEPD = L1” and 1-(2-Aminoethyl)piperazine “AEPz = L2” , were prepared. All synthesized compounds were identified and confirmed by elemental analyses, molar conductivity and spectral analyses (UV–Visible, IR and mass). Conductance measurement indicates that all the complexes are non-electrolytic in nature and the complexes were isolated in 1:1 molar ratio (metal: ligand). Thermal decomposition profiles were consistent with the proposed formulations. The ligands behave as a tridentate ligand through three nitrogen centers of donation. The nano-size was investigated by using transmission electron microscopy (TEM). The geometric structure properties were analyzed using density functional theory (DFT) for ligands and their Lanthanum (III) complexes. The complexes were screened against some bacteria strains, hepatocellular cell line and diphenylhydrazine free radical. The molecular docking active sites interactions were evaluated.     

Synthesis,spectral properties,crystal structures and biological activity of copper(II) pyridinecarboxylates with N -heterocyclic ligands

Synthesis and characterization of four new 2,6-dimethoxynicotinate (2,6-(MeO)₂nic) copper(II) monomeric complexes [Cu(2,6-(MeO)₂nic)₂(py)₂] (py is pyridine), [Cu{2,6-(MeO)₂nic}₂(Etnic)₂(H₂O)] (Etnic is ethylnicotinate), [Cu{2,6-(MeO)₂nic}₂(Et₂nia)₂(H₂O)₂] (Et₂nia is N,N-diethylnicotinamide) as well as of the polymeric complex [Cu{2,6-(MeO)₂nic}₂(ron)₂] _n (ron is ronicol) are reported. The characterizations were based on elemental analysis, infrared, electronic and EPR spectra. Crystal structures of two of the complexes have been determined. The copper(II) of [Cu{2,6-(MeO)₂nic}₂(py)₂] has a distorted tetragonal-bipyramidal (4 + 2) coordination environment. Both 2,6-(MeO)₂nic anions are asymmetrically chelating. The Cu(II) of [Cu{2,6-(MeO)₂nic}₂(Etnic)₂(H₂O)] is pentacoordinate in a slightly distorted tetragonal-pyramidal arrangement by two trans nitrogens, each of one Etnic, by two oxygens, each of the carboxyl group of one unidentate 2,6-(MeO)₂nic and the axial position occupied by water at a longer distance. Antimicrobial effects of the complexes have been tested on various strains of bacteria, yeasts and filamentous fungi. While the 2,6-(MeO)₂nicH alone did not influence the model bacteria growth, dimeric [Cu{2,6-(MeO)₂nic}₂(H₂O)]₂ and polymeric [Cu{2,6-(MeO)₂nic}₂(ron)₂] _n have pronounced influence on the growth of Staphylococcus aureus, Escherichia coli and Candida parapsilosis.     

Synthesis,characterization and biological properties of novel ON donor bidentate Schiff bases and their copper(II) complexes

Four novel ON donor Schiff bases (E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol (HL₁),(E)-3-((4-(4-biphenyloxy)phenyliminomethyl)benzene-1,2-diol (HL₂), (E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol (HL₃), (E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol (HL₄) and their copper(II) complexes bis((E)-3-((4-phenoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₁)₂) bis((E)-3-((4-(4-biphenyloxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₂)₂), bis((E)-3-((4-naphthoxyphenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₃)₂), bis((E)-3-((4-(2-naphthoxy)phenylimino)methyl)benzene-1,2-diol) copper(II) (Cu(L₄)₂) have been synthesized and characterized by spectroscopic (FTIR, NMR, UV–visible) and elemental analysis. The crystal structures of HL₁, HL₂, HL_3, and HL₄ have been determined, which reveal intramolecular N-H?O (HL₁, HL₂, HL_3, and HL₄) hydrogen bonds in the solid state. Keto-amine and enol-imine tautomerism is exhibited by the Schiff bases in solid and solution states. The Schiff bases and their copper(II) complexes have been screened for their biological activities. In antimicrobial assays (antibacterial and antifungal), HL₄ showed promising results against all strains through dual inhibition property while the rest of the compounds showed activity against selective strains. On the other hand, in cytotoxic, DPPH, and inhibition of hydroxyl (OH) free radical-induced DNA damage assays, the results were found significantly correlated with each other, i.e. the ligands HL₁ and HL₂ showed moderate activity while their complexes Cu(L₁)₂ and Cu(L₂)₂ exhibited prominent increase in activity. As the results of these assays are supporting each other, it represents the strong positive correlation and antioxidant nature of investigated compounds.     

Ferrocenyl-nitrogen donor ligands. Synthesis and characterization of rhodium(I) complexes of ferrocenylpyridine and related ligands

The preparation of a series of complexes of the types [RhCl(CO)₂(L)], [RhCl(cod)(L)] and [Rh(cod)(L)₂]ClO₄, where L is a ligand incorporating a ferrocenyl group and a pyridine ring is described. Complexes were characterized using NMR, IR and electronic spectroscopy. The electrochemical behaviour of the complexes was examined using cyclic voltammetry. The X-ray structures of three of the complexes, [RhCl(CO)₂{NC₅H₄CNC₆H₄(η⁵-C₅H₄)Fe(η⁵-C₅H₅)}], [RhCl(cod)(3-Fcpy)] and [RhCl(cod){3-Fc(C₆H₄)py}], were determined.